eValuate™ - concept screening

eValuate is a simple, fast and cost-effective concept screening technique designed to identify and protect ideas that are likely to succeed.

Finding the next big idea and keeping it alive

There are many advantages to robust early stage concept screening. Unfortunately, conventional research tends to kill breakthrough ideas. eValuate is different; unlike other screening tools, it doesn't just predict mainstream wins, it lets you identify great ideas the market isn't ready for yet.

Our expertise in concept screening

By asking a small number of questions - all proven success pointers - to early adopters as well as mainstream consumers, eValuate covers the maximum market potential of a new idea.

Whenever possible, eValuate screens ideas online, letting participants see up to six concepts. Using a simple traffic light system, it provides clients with a clear indication of the potential of their ideas, allowing them to put their resources behind the winners, thereby increasing their chances of success.

Our global database of over 60,000 cases provides us with an in-depth understanding of the drivers of long term potential.

A global insight brand

eValuate is a proven concept screening tool, validated using our global experience in over 60,000 real-life innovation cases, enabling comparability and learning across 60 markets, 55 categories and over 200 sub-categories.

Useful Contacts

TNS Global Market Research - Kirk Ward
  • Kirk Ward
  • TNS
  • 8040 Old Cedar
  • Avenue South
  • Minneapolis
  • USA
  • MN 55425-1211
Send a message
Select a country

Useful Contacts

Helen Wing
  • Helen Wing
  • TNS
  • 222 Grays Inn Road
  • London
  • WC1X 8HB
  • United Kingdom
Send a message
Select a country

© 1998-2010 TNS Group, a Kantar Group Company. All rights reserved.
Registered office: 222 Grays Inn Road, London WC1X 8HB. Registered in England and Wales number 912624